Drug Shortage Report for ETOPOSIDE INJECTION
Report ID | 61368 |
Drug Identification Number | 02080036 |
Brand name | ETOPOSIDE INJECTION |
Common or Proper name | ETOPOSIDE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ETOPOSIDE |
Strength(s) | 20MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS |
Packaging size | 25ML |
ATC code | L01CB |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-09-12 |
Estimated end date | 2020-03-31 |
Actual end date | 2020-03-15 |
Shortage status | Resolved |
Updated date | 2020-03-16 |
Company comments | Allocating Inventory until next supply (1/31) for 100% of Market, will then be out until end of March. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v29 | 2020-03-16 | French | Compare |
v28 | 2020-03-16 | English | Compare |
v27 | 2019-11-28 | French | Compare |
v26 | 2019-11-28 | English | Compare |
v25 | 2019-10-31 | French | Compare |
v24 | 2019-10-31 | English | Compare |
v23 | 2019-10-31 | French | Compare |
v22 | 2019-10-31 | English | Compare |
v21 | 2019-10-24 | French | Compare |
v20 | 2019-10-24 | English | Compare |
v19 | 2019-10-17 | French | Compare |
v18 | 2019-10-17 | English | Compare |
v17 | 2019-09-19 | French | Compare |
v16 | 2019-09-19 | English | Compare |
v15 | 2019-08-29 | French | Compare |
v14 | 2019-08-29 | English | Compare |
v13 | 2019-08-22 | French | Compare |
v12 | 2019-08-22 | English | Compare |
v11 | 2019-07-31 | French | Compare |
v10 | 2019-07-31 | English | Compare |